EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project

Irina Midenfjord, Mahrukh Khadija, Elias Sundelin, Inês A. Trindade, Hans Törnblom, Javier Santos, Beatriz Lobo, Danique Mulder, Alejandro Arias Vasquez, Georgy Ruesing, Andreas Reif, Mareike Aichholzer, Maaike Van Den Houte, Lukas Van Oudenhove, Maria Chiara Matteucci, Giovanni Barbara, Michelle Bosman, Daisy Jonkers, Josep Antoni Ramos‐Quiroga, Eva Jekkel, István Bitter, Andrei‐Vasile Pop, Dan Lucian Dumitrascu, Carmen Alonso‐Cotoner, Amanda Rodríguez‐Urrutia, Magnus Simrén

United European Gastroenterology Journal · 2026-02 · 14 (1)

DOI: 10.1002/ueg2.70157 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Patients with Irritable bowel syndrome (IBS) frequently suffer from comorbid psychiatric or somatic conditions, but the association with overall GI symptom severity and disease burden in IBS has not yet been established. Objective This pan‐European project, the DISCOvERIE project, aimed to characterize IBS patients with and without comorbid psychiatric (anxiety, depression) and/or somatic (fibromyalgia, chronic fatigue syndrome) conditions, and to compare them with disease (psychiatric and/or somatic condition without IBS) and healthy controls to further elucidate the effect of comorbid conditions on the disease burden in IBS. Methods Participants from nine different European centers were included: IBS patients (Rome IV criteria) with and without comorbid conditions, disease controls, and healthy controls. The presence of comorbidities was assessed through the Mini International Neuropsychiatric Interview (MINI) for anxiety or depression or through diagnostic criteria for fibromyalgia or chronic fatigue syndrome. Validated questionnaires on IBS (IBS‐SSS), depressive (PHQ‐9), anxiety (GAD‐7) and somatic symptom severity (PHQ‐12), fibromyalgia symptoms (FIQ) and fatigue (MFI) were completed. Results In total, 842 participants were recruited between March 2021 and January 2023, of which 607 had IBS, 161 were disease controls and 74 were healthy controls. IBS, anxiety, depression, somatic symptoms and fatigue were more severe in IBS patients with comorbidities compared with IBS patients without comorbidities. The severity of the abovementioned symptoms all increased gradually with increasing number of comorbidities (all p < 0.001). Conclusion This large pan‐European study highlights the significant impact of psychiatric and somatic comorbidities in IBS, and their strong link with outcomes and disease burden.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →